<table border="1" id="table_6" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6. Ritonavir Pharmacokinetic Characteristics</caption>
<col span="1" width="32%"></col>
<col span="1" width="34%"></col>
<col span="1" width="32%"></col>
<tbody>
<tr>
<td>
<content stylecode="bold">Parameter</content>
</td>
<td>
<content stylecode="bold">N</content>
</td>
<td>
<content stylecode="bold">Values (Mean ± SD)</content>
</td>
</tr>
<tr>
<td>V<sub>β</sub>/F<sup>‡</sup>
</td>
<td>91</td>
<td>0.41 ± 0.25 L/kg</td>
</tr>
<tr>
<td>t<sub>½</sub>
</td>
<td> </td>
<td>3 - 5 h</td>
</tr>
<tr>
<td>CL/F SS<sup>†</sup>
</td>
<td>10</td>
<td>8.8 ± 3.2 L/h</td>
</tr>
<tr>
<td>CL/F<sup>‡</sup>
</td>
<td>91</td>
<td>4.6 ± 1.6 L/h</td>
</tr>
<tr>
<td>CL<sub>R</sub>
</td>
<td>62</td>
<td>&lt; 0.1 L/h</td>
</tr>
<tr>
<td>RBC/Plasma Ratio</td>
<td> </td>
<td>0.14</td>
</tr>
<tr>
<td>Percent Bound*</td>
<td> </td>
<td>98 to 99%</td>
</tr>
<tr>
<td>†   SS = steady state; patients taking ritonavir 600 mg q12h.<br/>‡   Single ritonavir 600 mg dose.<br/>*   Primarily bound to human serum albumin and alpha-1 acid glycoprotein over the ritonavir concentration range of 0.01 to 30 µg/mL.</td>
</tr>
</tbody>
</table>